CN102406735A - Immature bitter orange or bitter orange total flavonoid extract decocted and extracted by water and its purpose - Google Patents
Immature bitter orange or bitter orange total flavonoid extract decocted and extracted by water and its purpose Download PDFInfo
- Publication number
- CN102406735A CN102406735A CN2011103722129A CN201110372212A CN102406735A CN 102406735 A CN102406735 A CN 102406735A CN 2011103722129 A CN2011103722129 A CN 2011103722129A CN 201110372212 A CN201110372212 A CN 201110372212A CN 102406735 A CN102406735 A CN 102406735A
- Authority
- CN
- China
- Prior art keywords
- fructus aurantii
- water
- ethanol
- aurantii immaturus
- decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to an immature bitter orange or bitter organe total flavonoid extract. The preparation method comprises the following steps: immature bitter orange or bitter orange is weighted, sliced into decoction pieces or crushing, 4-15 times water is added, decocted 1-3 times, wherein each decoction and extraction time is 1-3 hours, decocted fluid is merged and filtrated, a filtrate is passed through a processed non-polar macroporous resin, impurities are successively eluted by using water and less than 20% of ethanol and removed, and eluted by 25-90% of ethanol and 0.5-2% of sodium hydroxide, an ethanol eluate is collected and carried out pressure reduction and condensation to obtain a fluid extract with relative density of 1.20-1.40 (50 DEG C-70 DEG C), pressure reduction and drying are carried out, wherein the drying temperature is 60-80 DEG C, crushed to obtain the immature bitter orange or bitter orange total flavonoid extract. The immature bitter orange or bitter orange total flavonoid extract can be used for preparing medicines for treating stomach and intestine functional dyspepsia, epigastric pain, abdominal distension, apocleisis, eructation, nausea, emesis and emesis caused by chemotherapeutics or other reasons, and the extract of the invention can be prepared to medicinally acceptable drugs.
Description
Technical field
The present invention relates to Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone of a kind of water boiling and extraction and uses thereof.
Background technology
Functional dyspepsia (FD) is a kind of common, frequently-occurring disease.Be called gastric dynamic dysfunction again, or gastric motility disorder.Be a kind of common clinical syndrome, the foreign statistic data shows that 1/3 crowd suffered from FD, accounts for 20%~30% of gop number.Domestic account for digestion be out-patient about 50%, betide 20%~40% normal population.In addition, can cause vomiting after the tumor patient chemotherapy more than 80%, preventing or arresting vomiting is main with medicines such as paspertin metoclopramide, ondansetrons mainly, but the chemical medicine preventing or arresting vomiting is with asthenia, dizziness, headache, even nape muscle spasm symptom might occur.
Western medical treatment is main with motilium, cisapride, mosapride etc. mainly at present; But with its a large amount of uses, finding has obvious heart toxic and side effects, and many patients the Q-T interval occurs and prolong and arrhythmia after using cisapride, serious adverse reaction such as torsades de pointes type chamber speed particularly, even cause death.For this reason, FDA Food and Drug Administration is decided by that on July 23rd, 2000 rose and stops to use this medicine that China Drug Administration has also made qualification to the use of cisapride, uses but still can instruct down the doctor.
Chinese traditional treatment is with the dispelling the stagnated QI removing food stagnancy, and the painful abdominal mass class Chinese medicine that looses reduces phlegm; Stop in treatment is stagnant, feeling of fullness distending pain etc., Fructus Aurantii Immaturus is one of representative medicine.Fructus Aurantii Immaturus, Fructus Aurantii are dry young fruit or the immature fruit of rutaceae Citrus aurantium Linn. Citrus aurantium L. and variety or Fructus Citri sinensis Citrus sinensis Osbeckr.Fructus Aurantii Immaturus, Fructus Aurantii are from Shennong's Herbal, " Mingyi Bielu " record: " removing breast side of body accumulation of phlegm in the hypochondrium; by cutting off the water; broken solid; that relieving distension is full ", from Jin Dynasty Lee physician Dong Yuan " differentiation on endogenous " the initiative zhishi daozhi pills to make by hand, clinical formulation application and modern Chinese medicine large-scale production and be used for digestive tract disease up till now, there is nearly 2,000 years history front and back; Fructus Aurantii Immaturus, Fructus Aurantii main component are flavone etc., and its decocting liquid and Hesperidin etc. can significantly strengthen normal mouse and atropine produces the ahead running that mice suppresses the small intestinal of model, has the effect of short digestive tract power.But Fructus Aurantii Immaturus, Fructus Aurantii only are used for clinical formulation and Chinese patent medicine preparation on a small quantity, and ample resources is not used widely, and its natural dispelling the stagnated QI removing food stagnancy effect possibly promote that the effect class same sex of medicine for stomach dynamic is not fully excavated with the modern times.
Summary of the invention
The purpose of this invention is to provide a kind of Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone of water boiling and extraction, be used for gastrointestinal motility obstruction type functional dyspepsia; Upper abdominal pain, abdominal distention, anorexia, belch, feel sick, vomiting that vomiting and chemotherapeutics or other reasons cause.
Fructus Aurantii Immaturus provided by the invention or Fructus Aurantii extractive of general flavone, through Fructus Aurantii Immaturus or Fructus Aurantii are obtained with water boiling and extraction, wherein boiling water extraction method is: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing; Add 4~15 times of water gagings, decoct 1~3 time, the each decoction extracted 1~3 hour, merged decoction liquor; Filter, the non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, reuse 25~90% ethanol, 0.5~2% sodium hydroxide eluting; Collect ethanol elution, be evaporated to the fluid extract of relative density about 1.20~1.40 (50 ℃~70 ℃), drying under reduced pressure; Exsiccant temperature is 60~80 ℃, pulverizes, and promptly gets.
Preferably, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~13 times of water gagings; Decoct 2~3 times, the each decoction extracted 1~2.5 hour, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, reuse 30%~85% ethanol, 0.5~1.8% sodium hydroxide eluting; Collect ethanol elution, be evaporated to the fluid extract of relative density about 1.25~1.40 (55 ℃~70 ℃), drying under reduced pressure; Exsiccant temperature is 65~80 ℃, pulverizes, and promptly gets.
Preferably, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~11 times of water gagings; Decoct 2~3 times, the each decoction extracted 1.5~2.5 hours, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, reuse 35%~75% ethanol, 0.5~1.6% sodium hydroxide eluting; Collect ethanol elution, be evaporated to the fluid extract of relative density about 1.25~1.35 (55 ℃~65 ℃), drying under reduced pressure; Exsiccant temperature is 70~80 ℃, pulverizes, and promptly gets.
Preferably, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~9 times of water gagings; Decoct 3 times, the each decoction extracted 1.5~2 hours, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, reuse 40%~65% ethanol, 0.5~1.3% sodium hydroxide eluting; Collect ethanol elution, be evaporated to the fluid extract of relative density about 1.30~1.35 (60 ℃~65 ℃), drying under reduced pressure; Exsiccant temperature is 70~75 ℃, pulverizes, and promptly gets.
Preferably, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~7 times of water gagings; Decoct 3 times, the each decoction extracted 2 hours, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, reuse 45%~55% ethanol, 0.8~1.2% sodium hydroxide eluting; Collect ethanol elution, be evaporated to the fluid extract of relative density about 1.30 (60 ℃), drying under reduced pressure; Exsiccant temperature is 75 ℃, pulverizes, and promptly gets.
Preferably, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~8 times of water gagings; Decoct 2 times, the each decoction extracted 1.5 hours, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, and reuse 40%~55% ethanol, 0.7~1.3% sodium hydroxide eluting are collected ethanol elution; Be evaporated to the fluid extract of relative density about 1.30 (60 ℃), drying under reduced pressure; Exsiccant temperature is 75 ℃, pulverizes, and promptly gets.
Preferably, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~6 times of water gagings; Decoct 2 times, the each decoction extracted 1.5 hours, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, and reuse 45%~50% ethanol, 0.9~1.1% sodium hydroxide eluting are collected ethanol elution; Be evaporated to the fluid extract of relative density about 1.30 (60 ℃), drying under reduced pressure; Exsiccant temperature is 75 ℃, pulverizes, and promptly gets.
Preferably, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, pulverize decocte with water 3 times; For the first time add 8 times of water gagings and boiled 2 hours, second and third time adds 6,4 times of amounts respectively and decocted 1 hour, filters merging filtrate; Water, 15% ethanol, 45% ethanol, 1% sodium hydroxide eluting are collected 45% ethanol elution successively, are evaporated to the fluid extract of relative density about 1.30 (60 ℃), drying under reduced pressure; Exsiccant temperature is 75 ℃, pulverizes, and promptly gets.
Preferably, wherein 15% ethanol part elution volume is that every 1ml resin is used the 3ml eluting, selects every 1ml resin to use the 4ml eluting during 45% ethanol elution.
Preferably, wherein Fructus Aurantii Immaturus or Fructus Aurantii are pulverized through 8 mesh sieves.
Preferably, general flavone content more than 50% wherein.
Preferably, general flavone content more than 80% wherein.
Preferably, wherein also comprise flavonoid chemical constituent and acceptable liposoluble ingredient medically thereof, the flavonoid chemical constituent contains one or more in naringin, neohesperidin, Hesperidin, new naringin, Radix seu Folium Tosicodendri Delavayi glucoside and the aglycon thereof.
Preferably, wherein naringin content, neohesperidin content reach more than 25% respectively.
Preferably, wherein the macroporous resin applied sample amount by resin volume (ml): crude drug quality (g) is 5: 1.
Preferably, wherein every 1ml resin goes up the appearance flow velocity between 1.25~1.55ml/h.
Preferably, the elution flow rate of wherein every 1ml resin is between 1.25~1.45ml/h, and said non-polar macroporous resin blade diameter length ratio is 1: 10, and the static adsorption time of last appearance back medicinal liquid is 1 hour.
Preferably, wherein said non-polar macroporous resin repeats after 8 times with the 5% sodium hydroxide solution immersion of 10 times of amounts 2 hours, and water is washed till neutrality; 3% hydrochloric acid solution of 10 times of amounts of reuse soaked 2 hours, and water is washed till neutral with the back use of regenerating.
On the one hand, the invention provides the purposes that Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone are used to prepare treatment gastrointestinal motility obstruction type functional dyspepsia disease medicament.
On the one hand, the invention provides the purposes that Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone are used to prepare the vomiting disease medicament that treatment chemotherapeutics or other reasons cause.
On the one hand, the invention provides the purposes that Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone are used to prepare treatment Upper abdominal pain disease medicament.
On the one hand, the invention provides the purposes that Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone are used to prepare treatment abdominal distention, anorexia, belch disease medicament.
On the one hand, the invention provides the purposes that Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone are used to prepare the nauseating disease medicament of treatment.
On the other hand, the present invention also provides a kind of Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone preparation, and said preparation is a main active with described Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone.
Experimental data proves that Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone that water boiling and extraction of the present invention obtains can be used for treating gastrointestinal motility obstruction type functional dyspepsia; Upper abdominal pain, abdominal distention, anorexia, belch, feel sick, vomiting that vomiting and chemotherapeutics or other reasons cause.
More importantly be that Fructus Aurantii Immaturus that the invention water boiling and extraction obtains or Fructus Aurantii extractive of general flavone are except that having the effect of significant promotion gastric motility, and be also extremely effective to the vomiting of drug-induceds such as cisplatin, has the unexistent effect of motilium.The heart toxic and side effects that does not have simultaneously cisapride, mosapride again, the cardiac safety risk that can thoroughly avoid cisapride, mosapride to cause.
And medical science and study of pharmacy personnel can't learn that in advance Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone that the invention water boiling and extraction obtains have above-mentioned good effect in advance under the prerequisite of not doing experiment.
In sum, the Fructus Aurantii Immaturus of water boiling and extraction acquisition of the present invention or Fructus Aurantii extractive of general flavone and uses thereof bring significant technique effect.
The specific embodiment
Embodiment 1
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces, add 7 times of water gagings, decoct 3 times; The each decoction extracted 1 hour, merged decoction liquor, filtered the D101 macroporous resin of filtrating through having handled well; Water, 18% ethanol elution are removed impurity successively, and reuse 35% ethanol, 0.5% sodium hydroxide eluting are collected 35% ethanol elution, are evaporated to the fluid extract of relative density about 1.25 (55 ℃); Drying under reduced pressure (60 ℃) is pulverized, and promptly gets.
Embodiment 2
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, pulverize, through 8 mesh sieves, decocte with water 3 times; For the first time add 8 times of water gagings and boiled 2.5 hours, second and third time adds 6,5 times of amounts respectively and decocted 1 hour, filters merging filtrate; The AB-8 macroporous resin column of filtrating through having handled well, water, 15% ethanol, 45% ethanol, 1% sodium hydroxide eluting are collected 45% ethanol elution successively, are evaporated to the fluid extract of relative density about 1.31 (65 ℃); Drying under reduced pressure (70 ℃) is pulverized, and promptly gets.
Embodiment 3
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces, add 8 times of water gagings, decoct 3 times; The each decoction extracted 1.5 hours, merged decoction liquor, filtered the D101 macroporous resin of filtrating through having handled well; Water, 16% ethanol elution are removed impurity successively, and reuse 40% ethanol, 0.6% sodium hydroxide eluting are collected 40% ethanol elution, are evaporated to the fluid extract of relative density about 1.20 (50 ℃); Drying under reduced pressure (65 ℃) is pulverized, and promptly gets.
Embodiment 4
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces, add 9 times of water gagings, decoct 2 times; The each decoction extracted 2 hours, merged decoction liquor, filtered the D101 macroporous resin of filtrating through having handled well; Water, 15% ethanol elution are removed impurity successively, and reuse 45% ethanol, 0.7% sodium hydroxide eluting are collected 45% ethanol elution, are evaporated to the fluid extract of relative density about 1.25 (55 ℃); Drying under reduced pressure (65 ℃) is pulverized, and promptly gets.
Embodiment 5
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, pulverize, through 8 mesh sieves, decocte with water 2 times; For the first time add 8 times of water gagings and boiled 2 hours, second and third time adds 7 times of amounts respectively and decocted 1 hour, filters merging filtrate; The D101 macroporous resin column of filtrating through having handled well, water, 14% ethanol, 40% ethanol, 0.9% sodium hydroxide eluting are collected 40% ethanol elution successively, are evaporated to the fluid extract of relative density about 1.32 (70 ℃); Drying under reduced pressure (70 ℃) is pulverized, and promptly gets.
Embodiment 6
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, pulverize, through 8 mesh sieves, decocte with water 3 times; For the first time add 8 times of water gagings and boiled 2 hours, second and third time adds 7,6 times of amounts respectively and decocted 1.0 hours, filters merging filtrate; The AB-8 macroporous resin column of filtrating through having handled well, water, 16% ethanol, 45% ethanol, 1.1% sodium hydroxide eluting are collected 45% ethanol elution successively, are evaporated to the fluid extract of relative density about 1.29 (60 ℃); Drying under reduced pressure (75 ℃) is pulverized, and promptly gets.
Embodiment 7
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, pulverize, add 10 times of water gagings, decoct 3 times; The each decoction extracted 1 hour, merged decoction liquor, filtered the AB-8 macroporous resin of filtrating through having handled well; Water, 14% ethanol elution are removed impurity successively, and reuse 50% ethanol, 0.8% sodium hydroxide eluting are collected 50% ethanol elution, are evaporated to the fluid extract of relative density about 1.30 (55 ℃); Drying under reduced pressure (65 ℃) is pulverized, and promptly gets.
Embodiment 8
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, pulverize, through 8 mesh sieves, decocte with water 3 times; For the first time add 8 times of water gagings and boiled 1.5 hours, second and third time adds 6 times of amounts respectively and decocted 1 hour, filters merging filtrate; The D101 macroporous resin column of filtrating through having handled well, water, 12% ethanol, 45% ethanol, 0.8% sodium hydroxide eluting are collected 45% ethanol elution successively, are evaporated to the fluid extract of relative density about 1.30 (60 ℃); Drying under reduced pressure (75 ℃) is pulverized, and promptly gets.
Embodiment 9
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, pulverize, add 11 times of water gagings, decoct 2 times; The each decoction extracted 1.5 hours, merged decoction liquor, filtered the AB-8 macroporous resin of filtrating through having handled well; Water, 13% ethanol elution are removed impurity successively, and reuse 55% ethanol, 0.9% sodium hydroxide eluting are collected 55% ethanol elution, are evaporated to the fluid extract of relative density about 1.30 (60 ℃); Drying under reduced pressure (70 ℃) is pulverized, and promptly gets.
Embodiment 10
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, pulverize, through 8 mesh sieves, decocte with water 2 times; For the first time add 8 times of water gagings and boiled 2 hours, second and third time adds 6,5 times of amounts respectively and decocted 1.5 hours, filters merging filtrate; The D101 macroporous resin column of filtrating through having handled well, water, 15% ethanol, 45% ethanol, 1% sodium hydroxide eluting are collected 45% ethanol elution successively, are evaporated to the fluid extract of relative density about 1.30 (60 ℃); Drying under reduced pressure (75 ℃) is pulverized, and promptly gets.Embodiment 11
Embodiment 11
Method for preparing: get Fructus Aurantii Immaturus or Fructus Aurantii, pulverize, through 8 mesh sieves, decocte with water 3 times; For the first time add 8 times of water gagings and boiled 2 hours, second and third time adds 6,4 times of amounts respectively and decocted 1 hour, filters merging filtrate; The D101 macroporous resin column of filtrating through having handled well, water, 15% ethanol, 45% ethanol, 1% sodium hydroxide eluting are collected 45% ethanol elution successively, are evaporated to the fluid extract of relative density about 1.30 (60 ℃); Drying under reduced pressure (75 ℃) is pulverized, and promptly gets.
Experimental data 1: extraction process optimization research
Flavonoid glycoside compound generally is soluble in hot water, methanol, ethanol, pyridine and the dilute alkaline soln, and indissoluble or be insoluble in the organic solvents such as benzene, ether, chloroform, petroleum ether.Main active in the Fructus Aurantii Immaturus is to be the flavanone constituents of representative with naringin and neohesperidin, and the polarity of these flavanones is all bigger than general flavones ingredient, in water soluble and the low-concentration ethanol, is soluble in the Diluted Alcohol solution of hot water or heat.
According to the physicochemical property of contained main chemical compositions in the medical material, with reference to relevant document, combine the trial test result simultaneously, adopt decocting to boil the method for purification by macroporous resin on the decoction liquor.
Investigate the rate of transform that index is respectively the rate of extract, general flavone content and total flavones
1. the extraction process condition is preferred
1.1 extraction choice of Solvent
The Fructus Aurantii Immaturus pulverizing medicinal materials is crossed 8 mesh sieves, get 12 parts, be divided into 4 groups, every group average three parts, water, 65% ethanol, 95% ethanol and saturated limewater decoct separately.The result sees table 1.
Table 1 extracts choice of Solvent
Conclusion: can be known that by table 1 the ethanol extraction total flavones rate of transform is lower, the water extraction total flavones rate of transform reaches more than 90%, but water is lower than 65% ethanol extraction effect, and comprehensive production cost in conjunction with the suitability for industrialized production practical situation, selects water for extracting solvent.
1.2 the selection of medical material granularity
The Fructus Aurantii Immaturus that crushes is sieved, respectively drink three parts of sheets, 8 orders, 20 orders, 40 orders, 60 orders, 120 orders, totally 18 parts, decocte with water respectively.The result sees table 2.
The selection of table 2 medical material granularity
Conclusion: can know by relevant data in the table 2; When water decocted, the granularity of medical material had very big difference, is not that the medical material granule is more carefully good more; Wherein the rate of transform with the rate of extract of crossing 8 mesh sieves and total flavonoid glycoside is the highest, so selection 8 orders are as the final grinding particle size of medical material.
1.3 the preferred extraction process of orthogonal experiment
According to above experimental result, existing with decocting time in the decoction process (A), decoct number of times (B), amount of water (C), decoct before four of soak times (D) as the investigation factor, each factor is established three levels, presses L9 (3
4) orthogonal table carries out orthogonal experiment design (table 3, table 4), investigating index is the rate of extract and the total flavonoid glycoside rate of transform.
Table 3 factor level table
Get 27 parts of Fructus Aurantii Immaturus medical materials (8 order), every group average three parts, totally nine groups, by table 4L9 (34) orthogonal test table design experiment.The result sees table 4.
Table 4L9 (3
4) orthogonal test table
(1) intuitive analysis:
From the rate of extract Ra optimised process: B
3C
3A
1D
1(B, C are principal element)
Total flavonoid glycoside rate of transform optimised process: B
3C
3A
1D
1(B, C are principal element)
(2) variance analysis
The result sees table 5.
Table 5 is the variance analysis of index with the total flavonoid glycoside rate of transform
*F
1-0.05(2,2)=19.0
**F
1-0.01(2,2)=99.0
(3) conclusion: intuitive analysis can know that it is bigger to decocting influential effect to decoct number of times (B) and solvent for use volume (C), and decocting time (A) and soak time (D) are less to decocting influential effect.With the rate of transform is that index is carried out variance analysis, and table 5 analysis result has further been verified the intuitive analysis conclusion, and promptly set factor C, B have considerable influence to decocting effect successively.Because factor A is less to decocting influential effect; And first liquid of boiling medicine does not also infiltrate the medical material organization internal fully; According to producing practical situation, first fries in shallow oil increase by a hour, confirms tentatively that thus decocting condition is: add 18 times of water gagings (with the medical material weight ratio) and carry (8 times, 6 times, 4 times) 3 times; Decocting time is respectively 2h, 1h, 1h, and medical material does not soak.
2. demonstration test
Get 3 parts of Fructus Aurantii Immaturus medical materials (crossing 8 mesh sieves), carry out demonstration test by the optimum extraction process condition that orthogonal test is chosen, that is: (8 times/2h, 6 times/lh, 4 times/1h) decoct respectively 3 times, medical material does not soak 18 times of water gagings.The result sees table 6.
Table 6 demonstration test is measured the result
Conclusion: can know by table 6, boil 3 times by the selection process decocting, total flavonoid glycoside existing 92% or more by fried, and three sample total flavonoid glycoside rates of transform more consistent (RSD is 1.73%), the result shows that last definite optimum extraction process is reasonable, stable.
Experimental data 2: the purification research of citrus aurantium total flavone extract
2.1 separation purifying technique is investigated
The Fructus Aurantii Immaturus medical material proposes a large amount of water-solubility impurities after with water extraction; Must be further purified processing to the water extract; To improve the content of flavonoids effective constituent, mostly water-solubility impurity is inorganic salt, saccharide, pectin and protein-based, and the active component in the Fructus Aurantii Immaturus is a flavone compound; According to flavonoid thing characteristic and present China isolation and purification method commonly used, therefore select to come this flavones ingredient of enriching and purifying with macroporous resin.
At first investigate experiment through preliminary applied sample amount, tentatively confirm appearance 5000ml extracting solution on every 1000ml macroporous resin, i.e. the resin volume: the crude drug quality is 4: 1.
Again further, investigate through applied sample amount, the macroporous resin adsorption 200g crude drug of finally confirming 1000ml is as final applied sample amount (being 0.2g crude drug/ml resin).
Afterwards,, confirm that 15% ethanol part elution volume confirms as 3000ml (being that every 1ml resin is with 3ml 15% ethanol elution), select with 4000ml (the 1ml resin is with 4ml 45% ethanol elution) during 45% ethanol elution through the investigation of elution volume.
Again further, through the investigation of last kind of flow velocity, confirm to go up the appearance flow velocity and should be chosen in better between 1250ml/h~1550ml/h (the upward appearance flow velocity that is every 1ml resin is between 1.25~1.55ml/h).
2.2 the orthogonal optimum seeking macroporous resin is optimized technology
According to above experimental result, existing blade diameter length ratio and three of static adsorption times of going up appearance back medicinal liquid with elution flow rate, macroporous resin, each factor was established three levels, presses L9 (3 as the investigation factor
4) orthogonal table carries out orthogonal experiment design (table 7, table 8), the investigation index is the content and the total flavonoid glycoside rate of transform of the rate of extract, total flavonoid glycoside.
Table 7 factor level table
Get Fructus Aurantii Immaturus medical material (crossing 8 mesh sieves) and extract, extracting solution is divided into 9 parts, and totally nine parts of every part of 4000ml (being equivalent to the 200g crude drug) medicinal liquids are by table 8L9 (3
4) on the macroporous resin (every resin dress 1000ml macroporous resin) of anticipating, use the water of 4000ml, ethanol, 4000ml 45% ethanol and 3000ml 95% ethanol elution of 3000ml 15% respectively.The result sees table 8.
Table 8L9 (3
4) orthogonal test table
(1) intuitive analysis
Analyze the rate of extract optimised process: A according to the R value
1B
3C
1(A is a principal element)
Analyze total flavonoid glycoside rate of transform optimised process: A according to the R value
1B
1C
2(A is a principal element)
(2) variance analysis
The result sees table 9, table 10.
Table 9 is the variance analysis of index with the rate of extract
Table 10 is the variance analysis of index with the total flavonoid glycoside rate of transform
ΔF
1-0.19(2,2)=9.00
*F
1-0.05(2,2)=19.0
(3) conclusion: intuitive analysis can know that the elution flow rate of resin (A) is a principal element, and static adsorption time (B) influence of blade diameter length ratio of macroporous resin (C) and last appearance back medicinal liquid is less.The rate of transform with the rate of extract and total flavonoid glycoside is that index is carried out variance analysis again, and analysis result has further been verified the intuitive analysis conclusion in the table 9,10, and promptly set factor A has considerable influence to elute effect.Because general flavone content is the leading indicator of this project, therefore, confirm that tentatively optimum condition is A
1B
1C
2That is: elution flow rate is 1250~1450ml/h (elution flow rate that is every 1ml resin is between 1.25~1.45ml/h), and blade diameter length ratio is 1: 10, and the static adsorption time of last appearance back medicinal liquid is 1 hour.
2.3 demonstration test and the test of resin access times
Get Fructus Aurantii Immaturus medical material (crossing 8 mesh sieves) and extract, extracting solution is taken as 13 parts, every part of 4000ml (being equivalent to the 200g crude drug), and cold preservation, subsequent use.
A. get 1 part and be splined on 1000ml macroporous resin (the resin column blade diameter length ratio is 1: 10), last appearance flow velocity is 1400ml/h, static adsorption 1 hour.Ethanol, 4000ml 45% ethanol and 3000ml 95% ethanol elution of water, 3000ml 15% of using 4000ml successively is with the flow velocity eluting of 1400ml/h.Collect 45% ethanol elution and carry out assay.The result sees table 11.
B. with a with after resin with washing to there not being the alcohol flavor, other gets this resin on the sample of a refrigerator cold-storage, the step reprocessing of pressing a.Resin carries out absorption next time (the same a.b of following steps) successively.
Table 11 demonstration test is measured the result
Conclusion: from table 11, can find out the demonstration test of being undertaken by optimised process, the sample total flavonoid glycoside content and the total flavonoid glycoside rate of transform that repeat 8 gained all increase.And each item index homogeneous of sample, stable, explain that this technology is best, stable.After using 8 times, need carry out Regeneration Treatment simultaneously to resin.
2.4 service test after the resin regeneration
5% sodium hydroxide solution of resin with 10 times of amounts soaked 2 hours, and water is washed till neutrality; 3% hydrochloric acid solution of 10 times of amounts of reuse soaked 2 hours, and water is washed till neutrality.The resin that regeneration is good by the following method absorb-elute 3 times successively of demonstration test and the test of resin access times, calculates the rate of extract, the Liquid Detection total flavonoid glycoside content and the rate of transform.The result sees table 12.
Service test after table 12 resin regeneration
Operating position was good after the result showed resin regeneration.
According to above-mentioned separation, purification research, merge extractive liquid, after the medicinal material extract filters, the D of filtrating through having handled well
101Macroporous resin column, water, 15% ethanol, 45% ethanol, 1% sodium hydroxide eluting are collected 45% ethanol elution successively.
Experimental data 3: the research of citrus aurantium total flavone extract drying means and baking temperature
Get Fructus Aurantii Immaturus medical material 1kg, totally 10 parts, according to above-mentioned definite extraction, purifying process; Behind extraction, purification; Collect 45% ethanol elution, decompression recycling ethanol also is concentrated into the extractum of relative density about 1.30 (60 ℃), adopts oven drying method, boulton process to compare research respectively to above-mentioned extractum.Oven drying method and boulton process carry out the comparison of 5 kinds of different temperatures (50 ℃, 65 ℃, 75 ℃, 85 ℃, 95 ℃) respectively.Investigate the content of total flavonoid glycoside.The result sees table 13 and table 14.
The mensuration result of table 13 oven drying method different temperatures
The mensuration result of table 14 boulton process different temperatures
Can know that from table 13,14 oven drying method is long than the dry required time of vacuum on same temperature levels, effect is not as vacuum drying.The sample color and luster of oven drying method oven dry is relatively poor, be difficult for pulverizing, and along with the rising of temperature, oven drying method is prone to because of hot-spot causes carbonization, thereby causes the color sample blackout, and effective ingredient is lost.Easy-to-drawly during vacuum drying driedly become cellular, help pulverizing, and color and luster is better, vacuum drying temperature is controlled at about 75 ℃ and is advisable simultaneously, saves time and can not cause losing of effective ingredient.
Below all select for use embodiment 11 Fructus Aurantii Immaturus total flavones glucoside extracts as experimental group
Experimental data 4: effect is told in Fructus Aurantii Immaturus total flavones glucoside extract town
4.1 the Fructus Aurantii Immaturus total flavones glucoside extract causes the influence of pigeon vomiting to copper sulfate
60 of pigeons, body weight 280~350g, male and female half and half.Be divided into 6 groups at random: matched group, embodiment 11 Fructus Aurantii Immaturus total flavones glucoside extracts (20,40,80,160mgkg
-1) 4 dose groups and positive drug group (fourth beautiful jade 40mgkg
-1), 10 every group, ♀
Half and half.Each is organized the pigeon fasting and can't help water 16 hours, next day single administration, matched group gives distilled water and irritates stomach, other groups are irritated stomach relative medicines, 10mlkg
-1Respectively organize pigeon after 1 hour and give 3.5% copper-bath 10mgkg
-1Irritate the stomach modeling.Record is respectively organized pigeon vomiting latent time and is vomitted number of times in 2 hours, and result of the test shows, the Fructus Aurantii Immaturus total flavones glucoside extract (20,40,80,160mgkg
-1) single administration all can not prolong the vomiting latent time of pigeon due to the copper sulfate, but the Fructus Aurantii Immaturus total flavones glucoside extract (40,80mgkg
-1) single administration can reduce the vomiting number of times of pigeon due to the copper sulfate, sees table 15.
Table 15 Fructus Aurantii Immaturus total flavones glucoside extract causes the influence
of pigeon vomiting to copper sulfate
Annotate: compare with matched group,
*P<0.05,
*P<0.01
4.2 the Fructus Aurantii Immaturus total flavones glucoside extract causes the influence of pigeon vomiting to cisplatin
80 of pigeons, body weight 280~350g, male and female half and half.Be divided into 8 groups at random: matched group, embodiment 11 Fructus Aurantii Immaturus total flavones glucoside extracts (20,40,80,160mgkg
-1) 4 dose groups and positive drug 3 groups of (fourth beautiful jade 80,160mgkg
-1With Ondansetron Hydrochloride injection 5ugkg
-1) 10 every group, ♀
Half and half.Each is organized the pigeon fasting and can't help water 16 hours, next day single administration, matched group gives distilled water and irritates stomach, other groups give relative medicine, pneumoretroperitoneum injection in 1 hour gives 13mgkg
-1Cisplatin for inj.Record is respectively organized pigeon vomiting latent time and is vomitted number of times in 4 hours, and result of the test shows, Fructus Aurantii Immaturus total flavones glucoside extract 80mgkg
-1Single administration can prolong the vomiting time of pigeon due to the cisplatin, but 20,40 and 160mgkg
-1The time all can not prolong the vomiting time of pigeon due to the cisplatin; The Fructus Aurantii Immaturus total flavones glucoside extract (80,160mgkg
-1) single administration can reduce the vomiting number of times of pigeon due to the cisplatin, sees table 16
Table 16 Fructus Aurantii Immaturus total flavones glucoside extract causes the influence
of pigeon vomiting to cisplatin
Annotate: compare with matched group,
*P<0.05,
*P<0.01
4.3 the Fructus Aurantii Immaturus total flavones glucoside extract causes the influence of hybrid dog vomiting to apomorphine
56 of hybrid dogs, body weight 8.0~10.0kg, male and female half and half.Be divided into 7 groups at random: matched group, embodiment 11 Fructus Aurantii Immaturus total flavones glucoside extracts (15,30,60,120mgkg
-1) 4 dose groups and 2 groups of (motilium 30mgkg of positive drug
-1With metoclopramide injection 1mgkg
-1), 8 every group, ♀
Half and half.Each is organized the fasting of hybrid dog and can't help water 16 hours, next day single administration, matched group gives distilled water and irritates stomach, other groups give relative medicine and irritate stomach, 5mlkg
-1Give 500ugkg after 1 hour
-1The apomorphine subcutaneous injection.Record is respectively organized hybrid dog vomiting latent time and is vomitted number of times in 1 hour.Result of the test shows, the Fructus Aurantii Immaturus total flavones glucoside extract (15,30,60,120mgkg
-1) single administration all can not reduce apomorphine and cause hybrid dog vomiting number of times; The Fructus Aurantii Immaturus total flavones glucoside extract (15,30,120mgkg
-1) also can not prolong the vomiting latent time that apomorphine causes the hybrid dog, but Fructus Aurantii Immaturus total flavones glucoside extract 60mgkg
-1The time can prolong the vomiting latent time of hybrid dog, see table 17.
Table 17 Fructus Aurantii Immaturus total flavones glucoside extract causes the influence
of hybrid dog vomiting to apomorphine
Annotate: compare with matched group,
*P<0.05
Experimental data 5: the Fructus Aurantii Immaturus total flavones glucoside extract is to the intestinal progradation
5.1 the Fructus Aurantii Immaturus total flavones glucoside extract causes the influence of the low mice of intestinal function to dopamine
70 of mices, body weight 19~22g is divided into 7 groups at random: matched group, model group, embodiment 11 Fructus Aurantii Immaturus total flavones glucoside extracts (25,50,100,200mgkg
-1) 4 dose groups and positive drug group (motilium 50mgkg
-1), 10 every group, ♀
Half and half.Each is organized the mice fasting and can't help water 16 hours, next day single administration, matched group is irritated the stomach distilled water, other groups give relative medicine and irritate stomach.Except that matched group, all the other mices give 1.7mgkg to each mouse stomach after 30 minutes
-1The modeling of dopamine hydrochloride inj subcutaneous injection, 70 mices are irritated respectively and obey 2% sodium carboxymethyl cellulose carbon powder suspension 0.2ml10g after 20 minutes
-1, mice takes off neck execution after 20 minutes, takes out gastrointestinal immediately, tiling, and the distance and the small intestinal total length of mensuration carbon powder front end to pylorus are calculated the propelling percentage rate with ratio between two.Result of the test shows, subcutaneous injection 1.7mgkg
-1The dopamine intestinal that can obviously suppress mice advance, the Fructus Aurantii Immaturus total flavones glucoside extract (25,50,100mgkg
-1) can improve the mice intestinal propelling activity that suppresses by dopamine, see table 18.
Table 18 Fructus Aurantii Immaturus total flavones glucoside extract causes the propulsive influence of mice intestinal
to dopamine
70 of mices, body weight 19~22g is divided into 7 groups at random: matched group, model group, embodiment 11 Fructus Aurantii Immaturus total flavones glucoside extracts (25,50,100,200mgkg
-1) 4 dose groups and positive drug group (motilium 50mgkg
-1), 10 every group, ♀
Half and half.Each is organized the mice fasting and can't help water 16 hours, next day single administration, matched group is irritated the stomach distilled water, other groups give relative medicine and irritate stomach.Except that matched group, all the other mices give 2.5mgkg to each mouse stomach after 30 minutes
-1The modeling of atropine subcutaneous injection, 70 mices are irritated the sodium carboxymethyl cellulose carbon powder suspension 0.2ml10g of clothes 2% respectively after 20 minutes
-1, mice takes off neck execution after 20 minutes, takes out gastrointestinal immediately, tiling, and the distance and the small intestinal total length of mensuration carbon powder front end to pylorus are calculated the propelling percentage rate with ratio between two.Result of the test shows, subcutaneous injection 2.5mgkg
-1The atropine intestinal that can obviously suppress mice advance, Fructus Aurantii Immaturus total flavones glucoside extract 50mgkg-1 can improve the mice intestinal propelling activity by the atropine inhibition, sees table 19.
Table 19 Fructus Aurantii Immaturus total flavones glucoside extract causes the propulsive influence of mice intestinal
to atropine
Annotate: compare with matched group,
ΔP<0.05; Compare with model group,
*P<0.05
5.3 the Fructus Aurantii Immaturus total flavones glucoside extract causes the influence of the low mice of intestinal function to epinephrine
70 of mices; Body weight 19~22g; Be divided into 7 groups at random: matched group, model group, embodiment 11 Fructus Aurantii Immaturus total flavones glucoside extracts (25,50,100,200mgkg-1) 4 dose groups and positive drug groups (motilium 50mgkg-1); Every group 10, ♀
half and half.Each is organized the mice fasting and can't help water 16 hours, next day single administration, matched group is irritated the stomach distilled water, other groups give relative medicine and irritate stomach.Except that matched group, all the other mices give 0.5mgkg to each mouse stomach after 30 minutes
-1The modeling of adrenalin hydrochloride injection subcutaneous injection; 70 mices are irritated respectively and obey 2% sodium carboxymethyl cellulose carbon powder suspension 0.2ml10g-1 after 20 minutes; Mice takes off neck execution after 20 minutes, takes out gastrointestinal immediately, tiling; Measure the distance and the small intestinal total length of carbon powder front end to pylorus, calculate with ratio between two and advance percentage rate.Result of the test shows, subcutaneous injection 0.5mgkg
-1The epinephrine intestinal that can obviously suppress mice advance, the Fructus Aurantii Immaturus total flavones glucoside extract (25,50,100,200mgkg
-1) all can not improve mice intestinal propelling activity by epinephrine inhibited, see table 20.
Table 20 Fructus Aurantii Immaturus total flavones glucoside extract causes the propulsive influence of mice intestinal
to epinephrine
Annotate: compare with matched group,
The Δ ΔP<0.01
Experimental data 6: the Fructus Aurantii Immaturus total flavones glucoside extract is to gastric secretion, gastric acid and pepsic influence
6.1 influence to gastric secretion, gastric acid
48 of rats, body weight 230~270g is divided into 6 groups at random: matched group, embodiment 11 Fructus Aurantii Immaturus total flavones glucoside extracts (20,40,80,160mgkg
-1) 4 dose groups and positive drug group (motilium 40mgkg
-1), 8 every group, ♀
Half and half.The rat fasting can't help water 36 hours before the test, gastric infusion of rat, and matched group gives distilled water, and other groups give relative medicine.The administration while, each rat is opened the abdominal cavity under the ether light anaesthesia, the ligation pylorus, and 5 hours rat gastric juice behind the collection pylorus ligation, with the centrifugal 5min of 3000r/min, gastric contents such as place to go food debris are with the accurate weighing gastric juice of graduated cylinder amount.Measure gastric juice 1ml; Place conical flask to add the equivalent distilled water, mix homogeneously adds each 2 of free acid indicator 0.5% pair of dimethyl azoaniline alcoholic solution and total acid indicator 0.5% phenolphthalein alcoholic solution; If contain hydrochloric acid, promptly be cherry red in the mixing gastric juice.With the NaOH of burette dropping 0.01mol/L,, limit edged shaking flasks to red color disappeared, begins to occur till the orange colour.Be the terminal point of free hydrochloric acid.Write down the amount that spends till NaOH no longer deepens to redness, be the terminal point of total acidity.Write down twice titration and spend NaOH solution total amount.Calculate concentration and total secretory volume of free hydrochloric acid and total acid.Result of the test shows, the Fructus Aurantii Immaturus total flavones glucoside extract (20,40,80mgkg
-1) gastric secretion of pylorus ligation rat there is not obvious influence, but Fructus Aurantii Immaturus total flavones glucoside extract 160mgkg
-1Can reduce the gastric secretion of rat; The Fructus Aurantii Immaturus total flavones glucoside extract (80,160mgkg
-1) concentration of can raise pylorus ligation rat free hydrochloric acid and total acid, but each dosage of Fructus Aurantii Immaturus total flavones glucoside extract (20,40,80,160mgkg
-1) secretory volume of free hydrochloric acid and total acid there is not influence, see table 21.
Table 21 Fructus Aurantii Immaturus total flavones glucoside extract is to the influence
of rat gastric secretion, free hydrochloric acid and total acid concentration
Annotate: compare with matched group,
*P<0.05,
*P<0.01
The capillary glass-tube that internal diameter 1~2mm thickness is well-balanced is cleaned and to be dried, and gets an amount of Ovum Gallus domesticus album and fully beats even back and use filtered through gauze, and above-mentioned glass capillary is utilized siphonage, fills Ovum Gallus domesticus album (manage planted agent do not have bubble sneak into).Be positioned over then in 85 ℃ of heat steams and make protein coagulating.After cooling, take out paraffin with the sealing of protein pipe two ends, subsequent use in the storage refrigerator.Get the conical flask that gastric juice 1ml puts into 50ml during experiment, add 0.05N hydrochloric acid solution 15ml, shake up, put two of long approximately 2.5cm protein pipe into.Filled in bottleneck, be put in 37 ℃ of calorstats temperature and incubate 24h.Measure the length (mm) of protein pipe two ends transparent part with chi and ask its meansigma methods, calculate pepsic unit=meansigma methods with formula with the value of four ends
2* 16.Result of the test shows, embodiment 11 each dosage of Fructus Aurantii Immaturus total flavones glucoside extract (20,40,80,160mgkg
-1) pepsin activity of pylorus ligation rat there is not obvious influence, see table 22.
Table 22 Fructus Aurantii Immaturus total flavones glucoside extract is to the influence
of rat free hydrochloric acid, total acid secretory volume and pepsin activity
Experimental data 7: the Fructus Aurantii Immaturus total flavones glucoside extract is to the influence of smooth muscle
7.1 influence to the gastrointestinal smooth muscle that exsomatizes
Select the healthy adult rat for use, the head of fiercelying attack causes dusk, takes out full stomach and duodenum stage casing 1-2cm rapidly, and the place cuts off along greater gastric curvature, with containing 95%O
2And 5%CO
2The Krebs liquid (composition: NaCl 117mmol/L, KCl 4.8mmol/L, CaCl of the fully saturated pH 7.35~7.45 of mist
22.5mmol/L, MgCl
21.2mmol/L, NaH
2PO
41.2mmol/L, NaHCO
325mmol/L, Glucose 11mmol/L) repeatedly the flushing exenterate; Get vertical at the bottom of the gastric antrum stomach function regulating, transversus bar and duodenum stage casing respectively and be about 1cm, wide about 0.5cm, the ventilation hook is fixed in the bottom; The upper end links to each other with transducer (JH-2 type muscular tension pick off); And it is inserted in the bath pipe that fills oxygen-saturated Krebs liquid (pH 7.35~7.45) 20ml, the adjustment preload is lg, whenever changes liquid once at a distance from 20min; In body lotion, inject oxygen through the ventilation hook, Application of B L-420E biological function experimental system its tension force of record and frequency.Outer tube through constant current infusion pump [continue, constant temperature (37 ± 0.5 ℃), constant speed (3~4ml/min)] perfusion to keep temperature in the bath.After treating that BIAO and BEN is stable, add medicine ultimate density to be measured and be respectively 0.25mg/L, 0.4mg/L, 0.55mg/L, 0.7mg/L, 0.85mg/L and 1.00mg/L, record is also observed medication front and back frequency and tension change.The isolated test result shows, embodiment 11 Fructus Aurantii Immaturus total flavones glucoside extract (0.25mg.ml
-1~1.0mg.ml
-1) can reduce vertical at the bottom of the gastric antrum stomach function regulating, horizontal shape flesh and duodenum smooth muscle tension force, suppress gastrointestinal motility, see table 23~27.
Table 23 Fructus Aurantii Immaturus total flavones glucoside extract is to the influence
of exsomatize gastric antrum transversal tension force and frequency
Annotate: with comparison before the administration,
*P<0.05,
*P<0.01
Table 24 Fructus Aurantii Immaturus total flavones glucoside extract is to the influence
of exsomatize gastric antrum longitudinal muscle tension force and frequency
Annotate: with comparison before the administration,
*P<0.05,
*P<0.01
Table 25 Fructus Aurantii Immaturus total flavones glucoside extract to the stomach that exsomatizes at the bottom of the influence
of transversal tension force and frequency
Annotate: with comparison before the administration,
*P<0.05,
*P<0.01
Table 26 Fructus Aurantii Immaturus total flavones glucoside extract to the stomach that exsomatizes at the bottom of the influence
of longitudinal muscle tension force and frequency
Annotate: with comparison before the administration,
*P<0.05,
*P<0.01
Table 27 Fructus Aurantii Immaturus total flavones glucoside extract is to the influence
of exsomatize duodenum stage casing tension force and frequency
Annotate: with comparison before the administration,
*P<0.05,
*P<0.01
7.2 to influence at body duodenum smooth muscle
56 of rats, body weight 180~230g is divided into 7 groups at random: matched group, model group, embodiment 11 Fructus Aurantii Immaturus total flavones glucoside extracts (20,40,80,160mgkg
-1) 4 dose groups and positive drug group (fourth beautiful jade 40mgkg
-1), 8 every group, ♀
Half and half.The rat oral gavage administration, matched group and model group give distilled water, and other groups give relative medicine.Each is organized the rat fasting and can't help water 16 hours, next day single administration, except that matched group, all the other rats give 1.5mgkg to each rat oral gavage after 30 minutes
-1The modeling of dopamine hydrochloride inj subcutaneous injection; Chloral hydrate anesthesia is opened the abdominal cavity along the abdomen median line, selects the duodenum about 2-3cm in stage casing; Be fixed on the intestinal segment two ends on the aperture of intestinal tube stationary pipes both sides with stitching thread; Stitching thread of reuse is sewn on an end on the intermediary intestinal wall of intestinal segment, and the other end is passed by intestinal tube stationary pipes central authorities and is connected on the JH-2 type muscular tension pick off, and writes down the tension force and the frequency of each rat preduodenal through BL-420E biological function experimental system.Result of the test shows, subcutaneous injection 1.5mgkg
-1Dopamine can obviously be suppressed at the tension force and the frequency of body rat preduodenal, the Fructus Aurantii Immaturus total flavones glucoside extract (20,40,80,160mgkg
-1) can improve tension force and frequency by the rat preduodenal of dopamine inhibition, see table 28.
Table 28 Fructus Aurantii Immaturus total flavones glucoside extract is to the influence
in body duodenum stage casing tension force and frequency
Annotate: compare with matched group,
ΔP<0.05; Compare with model group,
*P<0.05,
*P<0.01
Claims (15)
1. Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone are used to prepare the feel sick purposes of disease medicament of treatment, and said Fructus Aurantii Immaturus or Fructus Aurantii extractive of general flavone are through obtaining Fructus Aurantii Immaturus or Fructus Aurantii with water boiling and extraction, and wherein boiling water extraction method is: get Fructus Aurantii Immaturus or Fructus Aurantii; Be cut into decoction pieces or pulverizing, add 4~15 times of water gagings, decoct 1~3 time; The each decoction extracted 1~3 hour, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, the upward appearance flow velocity of wherein every 1ml resin is between 1.25~1.55ml/h, and water, the ethanol elution below 20% are removed impurity successively; Reuse 25~90% ethanol, 0.5~2% sodium hydroxide eluting are collected ethanol elution, are evaporated to the fluid extract of relative density about 1.20~1.40 (50 ℃~70 ℃); Drying under reduced pressure, exsiccant temperature are 60~80 ℃, pulverize; Promptly get, wherein general flavone content is more than 80%.
2. purposes as claimed in claim 1, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~13 times of water gagings; Decoct 2~3 times, the each decoction extracted 1~2.5 hour, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, reuse 30%~85% ethanol, 0.5~1.8% sodium hydroxide eluting; Collect ethanol elution, be evaporated to the fluid extract of relative density about 1.25~1.40 (55 ℃~70 ℃), drying under reduced pressure; Exsiccant temperature is 65~80 ℃, pulverizes, and promptly gets.
3. purposes as claimed in claim 2, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~11 times of water gagings; Decoct 2~3 times, the each decoction extracted 1.5~2.5 hours, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, reuse 35%~75% ethanol, 0.5~1.6% sodium hydroxide eluting; Collect ethanol elution, be evaporated to the fluid extract of relative density about 1.25~1.35 (55 ℃~65 ℃), drying under reduced pressure; Exsiccant temperature is 70~80 ℃, pulverizes, and promptly gets.
4. purposes as claimed in claim 3, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~9 times of water gagings; Decoct 3 times, the each decoction extracted 1.5~2 hours, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, reuse 40%~65% ethanol, 0.5~1.3% sodium hydroxide eluting; Collect ethanol elution, be evaporated to the fluid extract of relative density about 1.30~1.35 (60 ℃~65 ℃), drying under reduced pressure; Exsiccant temperature is 70~75 ℃, pulverizes, and promptly gets.
5. purposes as claimed in claim 4, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~7 times of water gagings; Decoct 3 times, the each decoction extracted 2 hours, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, reuse 45%~55% ethanol, 0.8~1.2% sodium hydroxide eluting; Collect ethanol elution, be evaporated to the fluid extract of relative density about 1.30 (60 ℃), drying under reduced pressure; Exsiccant temperature is 75 ℃, pulverizes, and promptly gets.
6. purposes as claimed in claim 3, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~8 times of water gagings; Decoct 2 times, the each decoction extracted 1.5 hours, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, and reuse 40%~55% ethanol, 0.7~1.3% sodium hydroxide eluting are collected ethanol elution; Be evaporated to the fluid extract of relative density about 1.30 (60 ℃), drying under reduced pressure; Exsiccant temperature is 75 ℃, pulverizes, and promptly gets.
7. purposes as claimed in claim 6, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, be cut into decoction pieces or pulverizing, add 4~6 times of water gagings; Decoct 2 times, the each decoction extracted 1.5 hours, merged decoction liquor, filtered; The non-polar macroporous resin of filtrating through having handled well, water, the ethanol elution below 20% are removed impurity successively, and reuse 45%~50% ethanol, 0.9~1.1% sodium hydroxide eluting are collected ethanol elution; Be evaporated to the fluid extract of relative density about 1.30 (60 ℃), drying under reduced pressure; Exsiccant temperature is 75 ℃, pulverizes, and promptly gets.
8. purposes as claimed in claim 1, concrete boiling water extraction method is following: get Fructus Aurantii Immaturus or Fructus Aurantii, pulverize decocte with water 3 times; For the first time add 8 times of water gagings and boiled 2 hours, second and third time adds 6,4 times of amounts respectively and decocted 1 hour, filters merging filtrate; Water, 15% ethanol, 45% ethanol, 1% sodium hydroxide eluting are collected 45% ethanol elution successively, are evaporated to the fluid extract of relative density about 1.30 (60 ℃), drying under reduced pressure; Exsiccant temperature is 75 ℃, pulverizes, and promptly gets.
9. purposes as claimed in claim 8, wherein 15% ethanol part elution volume is that every 1ml resin is used the 3ml eluting, selects every 1ml resin to use the 4ml eluting during 45% ethanol elution.
10. like each described purposes of claim 1-9, wherein Fructus Aurantii Immaturus or Fructus Aurantii are pulverized through 8 mesh sieves.
11. like each described purposes of claim 1~9; Wherein also comprise flavonoid chemical constituent and acceptable liposoluble ingredient medically thereof, the flavonoid chemical constituent contains one or more in naringin, neohesperidin, Hesperidin, new naringin, Radix seu Folium Tosicodendri Delavayi glucoside and the aglycon thereof.
12. like each described purposes of claim 11, wherein naringin content, neohesperidin content reach more than 25% respectively.
13. like each described purposes of claim 1~9, wherein the macroporous resin applied sample amount is by resin volume (ml): crude drug quality (g) is 5: 1.
14. like each described purposes of claim 1~9, the elution flow rate of wherein every 1ml resin is between 1.25~1.45ml/h, said non-polar macroporous resin blade diameter length ratio is 1: 10, and the static adsorption time of last appearance back medicinal liquid is 1 hour.
15. like each described purposes of claim 1~9, wherein said non-polar macroporous resin repeats after 8 times with the 5% sodium hydroxide solution immersion of 10 times of amounts 2 hours, water is washed till neutrality; 3% hydrochloric acid solution of 10 times of amounts of reuse soaked 2 hours, and water is washed till neutral with the back use of regenerating.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103722129A CN102406735A (en) | 2010-12-28 | 2010-12-28 | Immature bitter orange or bitter orange total flavonoid extract decocted and extracted by water and its purpose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103722129A CN102406735A (en) | 2010-12-28 | 2010-12-28 | Immature bitter orange or bitter orange total flavonoid extract decocted and extracted by water and its purpose |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010106082967A Division CN102048874B (en) | 2010-12-28 | 2010-12-28 | General flavone extractive of immature bitter orange or bitter orange extracted through water decoction and use of general flavone extractive |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102406735A true CN102406735A (en) | 2012-04-11 |
Family
ID=45909272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011103722129A Pending CN102406735A (en) | 2010-12-28 | 2010-12-28 | Immature bitter orange or bitter orange total flavonoid extract decocted and extracted by water and its purpose |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102406735A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102764327A (en) * | 2012-08-15 | 2012-11-07 | 四川泰康药业有限公司 | Method for extracting lemon bioflavonoids |
WO2014149424A1 (en) * | 2013-03-15 | 2014-09-25 | The Iams Company | Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting |
US10548935B2 (en) | 2013-03-15 | 2020-02-04 | Mars, Incorporated | Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748740A (en) * | 2004-09-17 | 2006-03-22 | 王英锋 | Imature bitter orange total flavone and its preparing mthod for its preparation and quality control method |
CN101062165A (en) * | 2007-06-18 | 2007-10-31 | 石任兵 | Citrus aurantium total flavone extract and the preparing method thereof |
-
2010
- 2010-12-28 CN CN2011103722129A patent/CN102406735A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748740A (en) * | 2004-09-17 | 2006-03-22 | 王英锋 | Imature bitter orange total flavone and its preparing mthod for its preparation and quality control method |
CN101062165A (en) * | 2007-06-18 | 2007-10-31 | 石任兵 | Citrus aurantium total flavone extract and the preparing method thereof |
Non-Patent Citations (2)
Title |
---|
吕署一等: "甜橙枳实黄酮类成分提取工艺研究", 《中国实验方剂学杂志》 * |
韩旭等: "枳壳总黄酮在D101大孔吸附树脂上的吸附特性研究", 《大连医科大学学报》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102764327A (en) * | 2012-08-15 | 2012-11-07 | 四川泰康药业有限公司 | Method for extracting lemon bioflavonoids |
CN102764327B (en) * | 2012-08-15 | 2014-04-09 | 四川泰康药业有限公司 | Method for extracting lemon bioflavonoids |
WO2014149424A1 (en) * | 2013-03-15 | 2014-09-25 | The Iams Company | Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting |
RU2670516C2 (en) * | 2013-03-15 | 2018-10-23 | Марс, Инкорпорейтед | Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting |
US10441623B2 (en) | 2013-03-15 | 2019-10-15 | Mars, Incorporated | Dietary composition and method for preventing, reducing, alleviating or treating idiopathic vomiting |
US10548935B2 (en) | 2013-03-15 | 2020-02-04 | Mars, Incorporated | Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting |
US11419912B2 (en) | 2013-03-15 | 2022-08-23 | Mars, Incorporated | Dietary composition for preventing, reducing, alleviating or treating idiopathic vomiting |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102068535B (en) | Immature bitter orange or bitter orange total flavonoids extract prepared by ethanol reflux and extraction and application thereof | |
CN103041118B (en) | Composition with effects of reducing blood sugar and reducing blood lipid | |
CN102698137B (en) | Composition with blood pressure reducing function and preparation method of same | |
CN102114102B (en) | Traditional Chinese medicine extract mixed preparation and application thereof | |
CN103301200A (en) | Astragalus membranaceus powder medicament as well as extraction method and use thereof | |
CN102512482A (en) | Euonymus alatus extract, blood-sugar-reducing activity thereof and application of euonymus alatus extract to preparation of products for reducing blood sugar | |
CN101972385B (en) | Method for preparing general flavone in star-of-Bethlehem and application thereof to antitumor, anti-inflammatory and analgesic medicines | |
CN102048874B (en) | General flavone extractive of immature bitter orange or bitter orange extracted through water decoction and use of general flavone extractive | |
CN101450127A (en) | Pawpaw total phenolic acid extract and use thereof | |
CN102406735A (en) | Immature bitter orange or bitter orange total flavonoid extract decocted and extracted by water and its purpose | |
CN103705725B (en) | Chinese medicine composition of a kind of moistening and cleaning throat antiinflammatory and preparation method thereof | |
CN106083972B (en) | A kind of momordica grosvenori alcohol derivatives monomer | |
CN103191238A (en) | Fructus aurantii immaturus or fructus aurantii total-flavonoid extract obtained through ethanol reflux extraction and application thereof | |
CN104906212A (en) | Semen hoveniae extracts with liver protection function and extraction and separation method and application thereof | |
CN101874841A (en) | Total glycosides extractive of morinda plants, as well as preparation method and application thereof | |
CN102397374B (en) | Immature bitter orange or bitter orange general flavone extract extracted in decoction way through water and application thereof | |
CN102406734B (en) | Fructus aurantii immaturus or Fructus aurantii total flavone extract extracted by water decoction, and use thereof | |
CN106188205B (en) | A kind of purposes of momordica grosvenori alcohol derivatives monomer and combinations thereof | |
CN107582590A (en) | A kind of purposes of the white phoenix dish extractive of general flavone and preparation method thereof with treating acpuei pharyngitis | |
CN102397373B (en) | Immature bitter orange or bitter orange general flavone extract extracted in decoction way through water and application thereof | |
CN103191237A (en) | Fructus aurantii immaturus or fructus aurantii total-flavonoid extract obtained through ethanol reflux extraction and application thereof | |
CN103191239A (en) | Fructus aurantii immaturus or fructus aurantii total-flavonoid extract obtained through ethanol reflux extraction and application thereof | |
CN103191236A (en) | Fructus aurantii immaturus or fructus aurantii total-flavonoid extract obtained through ethanol reflux extraction and application thereof | |
CN103110680A (en) | Preparation method of total phenolic acid of erigeron breviscapus | |
CN1318034C (en) | Drug prepared by mulberry bark extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120411 |